Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany

被引:31
作者
Enders, M.
Turnwald-Maschler, A.
Regnath, T.
机构
[1] Inst Virol Infektiol & Epidemiol EV, Labor Enders & Partner, D-70193 Stuttgart, Germany
[2] Lab Grp Limbach, Dept Microbiol & Hyg, D-69126 Heidelberg, Germany
关键词
gonorrhoea; Neisseria gonorrhoea; E test; antimicrobial resistance; antimicrobial agents; epidemiology; Germany;
D O I
10.1007/s10096-006-0134-y
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of the present study was to determine prospectively the antimicrobial susceptibility of Neisseria gonorrhoeae strains collected in southern Germany (Heidelberg and Stuttgart areas). Sixty-five N. gonorrhoeae strains, isolated between July 2004 and June 2005 from patients with uncomplicated gonorrhoea, were tested. Minimum inhibitory concentrations of penicillin, tetracycline, ciprofloxacin, azithromycin, spectinomycin, ceftriaxone, and cefixime were determined by the E test. All isolates were fully susceptible to ceftriaxone, cefixime, and spectinomycin. However, 21.5% (14/65), 29.2% (19/65), and 47.7% (31/65) of isolates were resistant to penicillin (> 2.0 mg/l), tetracycline (> 2.0 mg/l), and ciprofloxacin (> 1.0 mg/l), respectively. Critical MICs of azithromycin (> 1.0 mg/l, as defined by the Neisseria Reference Laboratory at the Centers for Disease Control) were found for five (7.7%) N. gonorrhoeae isolates. These data indicate a high prevalence of N. gonorrhoeae strains resistant to the antimicrobial agents currently used to treat gonococcal infections in the Heidelberg and Stuttgart areas. Even though the findings may not be representative of the general population in Germany, they nevertheless illustrate the need to establish an antimicrobial resistance surveillance system in order to control gonorrhoea effectively.
引用
收藏
页码:318 / 322
页数:5
相关论文
共 19 条
[1]   Building a sentinel surveillance system for sexually transmitted infections in Germany, 2003 [J].
Bremer, V ;
Marcus, U ;
Hofmann, A ;
Hamouda, O .
SEXUALLY TRANSMITTED INFECTIONS, 2005, 81 (02) :173-179
[2]  
*CDCP, 2003, NEISS GON REF STRAIN
[3]   Amplified HIV transmission and new approaches to HIV prevention [J].
Cohen, MS ;
Pilcher, CD .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (09) :1391-1393
[4]   Recent trends in the epidemiology of sexually transmitted infections in the European Union [J].
Fenton, KA ;
Lowndes, CM .
SEXUALLY TRANSMITTED INFECTIONS, 2004, 80 (04) :255-263
[5]   Efficacy of azithromycin 1g single dose in the management of uncomplicated gonorrhoea [J].
Habib, AR ;
Fernando, R .
INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (04) :240-242
[6]   MULTICENTER TRIAL OF SINGLE-DOSE AZITHROMYCIN VS CEFTRIAXONE IN THE TREATMENT OF UNCOMPLICATED GONORRHEA [J].
HANDSFIELD, HH ;
DALU, ZA ;
MARTIN, DH ;
DOUGLAS, JM ;
MCCARTY, JM ;
SCHLOSSBERG, D ;
ARNO, JN ;
MROCZKOWSKI, TF ;
VINER, BL ;
MILLS, J ;
GARRISON, NA ;
VERDON, MS ;
WIGGINS, S ;
EHRET, M .
SEXUALLY TRANSMITTED DISEASES, 1994, 21 (02) :107-111
[7]   Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003 [J].
Kent, CK ;
Chaw, JK ;
Wong, W ;
Liska, S ;
Gibson, S ;
Hubbard, G ;
Klausner, JD .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) :67-74
[8]   COMPARATIVE-STUDIES OF AZITHROMYCIN IN SKIN AND SOFT-TISSUE INFECTIONS AND SEXUALLY-TRANSMITTED INFECTIONS BY NEISSERIA AND CHLAMYDIA SPECIES [J].
LASSUS, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :115-121
[9]   A CONTROLLED TRIAL OF A SINGLE DOSE OF AZITHROMYCIN FOR THE TREATMENT OF CHLAMYDIAL URETHRITIS AND CERVICITIS [J].
MARTIN, DH ;
MROCZKOWSKI, TF ;
DALU, ZA ;
MCCARTY, J ;
JONES, RB ;
HOPKINS, SJ ;
JOHNSON, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (13) :921-925
[10]   DRUGS 5 YEARS LATER - SPECTINOMYCIN [J].
MCCORMACK, WM ;
FINLAND, M .
ANNALS OF INTERNAL MEDICINE, 1976, 84 (06) :712-716